IRIS
GARUTI, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.037
AS - Asia 81
SA - Sud America 17
NA - Nord America 2
Totale 8.137
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.036
CN - Cina 53
VN - Vietnam 19
BR - Brasile 13
SG - Singapore 6
AR - Argentina 2
ID - Indonesia 2
US - Stati Uniti d'America 2
BH - Bahrain 1
EC - Ecuador 1
PY - Paraguay 1
RU - Federazione Russa 1
Totale 8.137
Salva come PNG Salva come JPEG
Città #
Genova 4.762
Genoa 2.053
Rapallo 731
Vado Ligure 479
Beijing 22
Bordighera 11
Ho Chi Minh City 6
Ashburn 2
Da Nang 2
Haiphong 2
Hanoi 2
Araraquara 1
Belén de Escobar 1
Cabreúva 1
Campo Bom 1
Ciudad del Este 1
Filadélfia 1
Guayaquil 1
Hamad Town 1
Hải Dương 1
Jandira 1
Jaraguá do Sul 1
Long An 1
Palmeira 1
Quảng Ngãi 1
Ribeirão Preto 1
Rio Grande 1
San Miguel de Tucumán 1
Santa Bárbara 1
Sidoarjo 1
Simão Dias 1
Singapore 1
São Carlos 1
Thái Bình 1
Tula 1
Viamão 1
Vĩnh Long 1
Vĩnh Tường 1
Totale 8.099
Salva come PNG Salva come JPEG
Nome #
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 221
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 206
APO866 activity in hematologic malignancies: a preclinical in vitro study. 205
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 184
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 181
Ras-induced resistance to lapatinib is overcome by MEK inhibition 178
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 178
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 172
A new human calpastatin skipped of the inhibitory region protects calpain-1 from inactivation and degradation 171
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 167
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 167
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 167
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 166
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 165
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 165
Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages 162
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 160
Uncovering the genomic heterogeneity of multifocal breast cancer 160
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 158
The increased activity of BACE1 correlates with oxidative stress in Alzheimer’s disease. 156
Circulating tumor DNA using tagged targeted deep sequencing to assess minimal residual disease in breast cancer patients undergoing neoadjuvant chemotherapy 154
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 153
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 152
B-Amyloid 1-42 and RAGE play a key role in ATRA-induced neuronal differentiation 151
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 151
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 151
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma 148
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 147
High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas. 147
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. 146
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 146
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer 145
Mutant presenilin 1 increases the expression and activity of BACE1. 143
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 143
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 141
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 138
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer 137
Germline mutations in the von Hippel-Lindau gene in Italian patients. 136
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 134
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 134
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib 132
Catastrophic NAD+ Depletion through Nampt Inhibition in Activated T Lymphocytes Reduces Demyelination and Disability in EAE. 130
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 126
Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia 125
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease 124
Reliability and reproducibility of a RNA preamplification method for low-density array analysis from formalin-fixed paraffin-embedded breast cancer samples. 122
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 121
Optimization of a wga-free molecular tagging-based ngs protocol for ctcs mutational profiling 121
Mutational analysis of BRCA1 and BRCA2 genes in high grade serous ovarian carcinoma with Next Generation Sequencing (NGS); correlation between somatic and germline mutations 103
The role of alpha-interferon in chronic myelogenous leukaemia in imatinib era. 101
Depletion of the intracellular coenzyme NAD plus in activated T-cells ameliorates experimental autoimmune encephalomyelitis 99
Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer 93
β-amyloid 1-42 induces physiological transcriptional regulation of BACE1. 90
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 88
Transcriptome Sequencing Of The Transition From Normal Epithelium To Invasive Cancer Reveals Insights Into The Carcinogenesis Of Hpv+ And Hpv- Vulvar Neoplasia 78
SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer 63
Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer 55
JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib 37
LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis 35
Totale 8.229
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.307
article - articoli 25.306
book - libri 0
conference - conferenze 675
curatela - curatele 0
other - altro 326
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.614
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021334 0 0 0 0 30 30 28 53 45 58 55 35
2021/2022789 28 59 66 110 28 50 52 168 34 63 46 85
2022/2023896 93 98 10 100 147 121 10 64 133 1 112 7
2023/2024487 20 53 4 69 33 98 19 38 19 18 37 79
2024/20251.318 47 85 43 90 151 110 116 278 37 51 142 168
2025/2026687 307 67 122 167 24 0 0 0 0 0 0 0
Totale 8.229